Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Alzheimer’s Therapeutic market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Alzheimer’s Therapeuticmarket, defines the market attractiveness level of Alzheimer’s Therapeutic market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Alzheimer’s Therapeutic industry, describes the types of Alzheimer’s Therapeutic market, the applications of major players and the market size, and deeply analyzes the current situation of the global Alzheimer’s Therapeutic market and the development prospects and opportunities of Alzheimer’s Therapeutic industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Alzheimer’s Therapeutic market in Chapter 13.
By Player:
Biotie Therapies
Axovant Sciences Ltd
Eli Lilly, Inc
Novartis International AG
Takeda Pharmaceutical Company Ltd
Astra Zeneca plc
Pfizer Inc
Acadia Pharmaceuticals, Inc
F Hoffman Le Roche
Merck & Co
H Lundbeck A/S
By Type:
Memantine Hydrochloride
Donepezil Hydrochloride
Rivastigmine
Galantamine Hydrobromide
By End-User:
Hospitals
Clinic
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Alzheimer’s Therapeutic Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Alzheimer’s Therapeutic Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Alzheimer’s Therapeutic Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Alzheimer’s Therapeutic Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Alzheimer’s Therapeutic Market Analysis and Outlook to 2022
-
7.1 Global Alzheimer’s Therapeutic Consumption (2017-2022)
-
7.2 United States Alzheimer’s Therapeutic Consumption (2017-2022)
-
7.3 Europe Alzheimer’s Therapeutic Consumption (2017-2022)
-
7.4 China Alzheimer’s Therapeutic Consumption (2017-2022)
-
7.5 Japan Alzheimer’s Therapeutic Consumption (2017-2022)
-
7.6 India Alzheimer’s Therapeutic Consumption (2017-2022)
-
7.7 South Korea Alzheimer’s Therapeutic Consumption (2017-2022)
8 Region and Country-wise Alzheimer’s Therapeutic Market Analysis and Outlook to 2028
-
8.1 Global Alzheimer’s Therapeutic Consumption Forecast (2022-2028)
-
8.2 United States Alzheimer’s Therapeutic Consumption Forecast (2022-2028)
-
8.3 Europe Alzheimer’s Therapeutic Consumption Forecast (2022-2028)
-
8.4 China Alzheimer’s Therapeutic Consumption Forecast (2022-2028)
-
8.5 Japan Alzheimer’s Therapeutic Consumption Forecast (2022-2028)
-
8.6 India Alzheimer’s Therapeutic Consumption Forecast (2022-2028)
-
8.7 South Korea Alzheimer’s Therapeutic Consumption Forecast (2022-2028)
9 Global Alzheimer’s Therapeutic Market Outlook by Types and Applications to 2022
-
9.1 Global Alzheimer’s Therapeutic Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Memantine Hydrochloride Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Donepezil Hydrochloride Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Rivastigmine Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Galantamine Hydrobromide Consumption and Growth Rate (2017-2022)
-
9.2 Global Alzheimer’s Therapeutic Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Alzheimer’s Therapeutic Market Outlook by Types and Applications to 2028
-
10.1 Global Alzheimer’s Therapeutic Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Memantine Hydrochloride Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Donepezil Hydrochloride Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Rivastigmine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Galantamine Hydrobromide Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Alzheimer’s Therapeutic Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Alzheimer’s Therapeutic Import and Export Analysis (Top 5 Countries)
-
11.1 Global Alzheimer’s Therapeutic Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Alzheimer’s Therapeutic Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Alzheimer’s Therapeutic Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Alzheimer’s Therapeutic Market Competitive Analysis
-
14.1 Biotie Therapies
-
14.1.1 Biotie Therapies Company Details
-
14.1.2 Biotie Therapies Alzheimer’s Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Biotie Therapies Alzheimer’s Therapeutic Product and Service
-
14.2 Axovant Sciences Ltd
-
14.2.1 Axovant Sciences Ltd Company Details
-
14.2.2 Axovant Sciences Ltd Alzheimer’s Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Axovant Sciences Ltd Alzheimer’s Therapeutic Product and Service
-
14.3 Eli Lilly, Inc
-
14.3.1 Eli Lilly, Inc Company Details
-
14.3.2 Eli Lilly, Inc Alzheimer’s Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Eli Lilly, Inc Alzheimer’s Therapeutic Product and Service
-
14.4 Novartis International AG
-
14.4.1 Novartis International AG Company Details
-
14.4.2 Novartis International AG Alzheimer’s Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis International AG Alzheimer’s Therapeutic Product and Service
-
14.5 Takeda Pharmaceutical Company Ltd
-
14.5.1 Takeda Pharmaceutical Company Ltd Company Details
-
14.5.2 Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Product and Service
-
14.6 Astra Zeneca plc
-
14.6.1 Astra Zeneca plc Company Details
-
14.6.2 Astra Zeneca plc Alzheimer’s Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Astra Zeneca plc Alzheimer’s Therapeutic Product and Service
-
14.7 Pfizer Inc
-
14.7.1 Pfizer Inc Company Details
-
14.7.2 Pfizer Inc Alzheimer’s Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Inc Alzheimer’s Therapeutic Product and Service
-
14.8 Acadia Pharmaceuticals, Inc
-
14.8.1 Acadia Pharmaceuticals, Inc Company Details
-
14.8.2 Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Product and Service
-
14.9 F Hoffman Le Roche
-
14.9.1 F Hoffman Le Roche Company Details
-
14.9.2 F Hoffman Le Roche Alzheimer’s Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 F Hoffman Le Roche Alzheimer’s Therapeutic Product and Service
-
14.10 Merck & Co
-
14.10.1 Merck & Co Company Details
-
14.10.2 Merck & Co Alzheimer’s Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Merck & Co Alzheimer’s Therapeutic Product and Service
-
14.11 H Lundbeck A/S
-
14.11.1 H Lundbeck A/S Company Details
-
14.11.2 H Lundbeck A/S Alzheimer’s Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 H Lundbeck A/S Alzheimer’s Therapeutic Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Alzheimer’s Therapeutic
-
Figure Alzheimer’s Therapeutic Picture
-
Table Global Alzheimer’s Therapeutic Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Alzheimer’s Therapeutic Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Alzheimer’s Therapeutic Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Alzheimer’s Therapeutic Consumption by Country (2017-2022)
-
Figure United States Alzheimer’s Therapeutic Consumption and Growth Rate (2017-2022)
-
Table Europe Alzheimer’s Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure China Alzheimer’s Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure Japan Alzheimer’s Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure India Alzheimer’s Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure South Korea Alzheimer’s Therapeutic Consumption and Growth Rate (2017-2022)
-
Figure Global Alzheimer’s Therapeutic Consumption Forecast by Country (2022-2028)
-
Figure United States Alzheimer’s Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Alzheimer’s Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Alzheimer’s Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Alzheimer’s Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Alzheimer’s Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Alzheimer’s Therapeutic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Memantine Hydrochloride Consumption and Growth Rate (2017-2022)
-
Figure Global Donepezil Hydrochloride Consumption and Growth Rate (2017-2022)
-
Figure Global Rivastigmine Consumption and Growth Rate (2017-2022)
-
Figure Global Galantamine Hydrobromide Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Memantine Hydrochloride Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Donepezil Hydrochloride Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rivastigmine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Galantamine Hydrobromide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Alzheimer’s Therapeutic Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Alzheimer’s Therapeutic Export by Region (Top 5 Countries) (2017-2028)
-
Table Biotie Therapies (Foundation Year, Company Profile and etc.)
-
Table Biotie Therapies Alzheimer’s Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biotie Therapies Alzheimer’s Therapeutic Product and Service
-
Table Axovant Sciences Ltd (Foundation Year, Company Profile and etc.)
-
Table Axovant Sciences Ltd Alzheimer’s Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Axovant Sciences Ltd Alzheimer’s Therapeutic Product and Service
-
Table Eli Lilly, Inc (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly, Inc Alzheimer’s Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly, Inc Alzheimer’s Therapeutic Product and Service
-
Table Novartis International AG (Foundation Year, Company Profile and etc.)
-
Table Novartis International AG Alzheimer’s Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis International AG Alzheimer’s Therapeutic Product and Service
-
Table Takeda Pharmaceutical Company Ltd (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Product and Service
-
Table Astra Zeneca plc (Foundation Year, Company Profile and etc.)
-
Table Astra Zeneca plc Alzheimer’s Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astra Zeneca plc Alzheimer’s Therapeutic Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Alzheimer’s Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Alzheimer’s Therapeutic Product and Service
-
Table Acadia Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Product and Service
-
Table F Hoffman Le Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffman Le Roche Alzheimer’s Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffman Le Roche Alzheimer’s Therapeutic Product and Service
-
Table Merck & Co (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Alzheimer’s Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Alzheimer’s Therapeutic Product and Service
-
Table H Lundbeck A/S (Foundation Year, Company Profile and etc.)
-
Table H Lundbeck A/S Alzheimer’s Therapeutic Sales, Price, Value and Gross Profit (2017-2022)
-
Table H Lundbeck A/S Alzheimer’s Therapeutic Product and Service
-
